MARKET

OSTX

OSTX

OS THERAPIES INCORPORATED
AMEX
1.830
-0.050
-2.66%
After Hours: 1.800 -0.03 -1.64% 19:59 09/08 EDT
OPEN
1.960
PREV CLOSE
1.880
HIGH
2.015
LOW
1.750
VOLUME
1.77M
TURNOVER
--
52 WEEK HIGH
2.350
52 WEEK LOW
1.150
MARKET CAP
85.04M
P/E (TTM)
-1.7151
1D
5D
1M
3M
1Y
5Y
1D
OS Therapies Reports Strong Survival Data for Bone Cancer Treatment
Benzinga · 13h ago
Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and Concentra Group Holdings Parent, Inc. (CON)
TipRanks · 15h ago
OS Therapies Announces Statistically Significant Benefit For OST-HER2-Treated Patients In An Interim 3-Year Overall Survival Data Analysis
Benzinga · 20h ago
OS Therapies Achieves Statistically Significant Benefit for OST-HER2-Treated Patients in Interim 3-Year Overall Survival Analysis of Phase 2b Pulmonary Metastatic Osteosarcoma Trial
Newsfile · 20h ago
Weekly Report: what happened at OSTX last week (0831-0904)?
Weekly Report · 1d ago
OS Therapies Provides OST-HER2 Metastatic Osteosarcoma Program Update and Announces Upcoming Conference Attendance
Newsfile · 6d ago
Weekly Report: what happened at OSTX last week (0824-0828)?
Weekly Report · 08/31 09:45
Weekly Report: what happened at OSTX last week (0817-0821)?
Weekly Report · 08/24 09:46
More
About OSTX
OS Therapies Incorporated is a clinical-stage oncology company focused on the identification, development, and commercialization of new class immunotherapy candidates for solid tumors, beginning with osteosarcoma and other solid tumors. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. Its lead asset, OST-HER2, is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH-sensitive silicone linkers (SiLinkers). Its clinical-stage cancer immunotherapy programs also include OST-AXAL for human papilloma virus (HPV)-associated cancers; OST-503 for non-small cell lung cancer (NSCLC) & glioblastoma; and OST-PSA for prostate cancer.

Webull offers OS Therapies Inc stock information, including AMEX: OSTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OSTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OSTX stock methods without spending real money on the virtual paper trading platform.